Treatment strategies aiming at remission in early rheumatoid arthritis patients: Starting with methotrexate monotherapy is cost-effective - Commentary

Tom Huizinga; Peter Nigrovic; Eric Ruderman; Hendrik Schulze-Koops

Treatment strategies aiming at remission in early rheumatoid arthritis patients: Starting with methotrexate monotherapy is cost-effective - Commentary

Tom Huizinga^*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

^*Corresponding author for this work

Medicine, Rheumatology Division

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	145-146
Number of pages	2
Journal	International Journal of Advances in Rheumatology
Volume	9
Issue number	4
State	Published - 2011

ASJC Scopus subject areas

Rheumatology

Cite this

@article{c2f17f20e522415c8f5d048125a6c02b,

title = "Treatment strategies aiming at remission in early rheumatoid arthritis patients: Starting with methotrexate monotherapy is cost-effective - Commentary",

author = "Tom Huizinga and Peter Nigrovic and Eric Ruderman and Hendrik Schulze-Koops",

year = "2011",

language = "English (US)",

volume = "9",

pages = "145--146",

journal = "International Journal of Advances in Rheumatology",

issn = "1478-856X",

publisher = "Remedica Medical Education and Publishing Ltd",

number = "4",

}

Treatment strategies aiming at remission in early rheumatoid arthritis patients: Starting with methotrexate monotherapy is cost-effective - Commentary. / Huizinga, Tom; Nigrovic, Peter; Ruderman, Eric et al.
In: International Journal of Advances in Rheumatology, Vol. 9, No. 4, 2011, p. 145-146.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Treatment strategies aiming at remission in early rheumatoid arthritis patients

T2 - Starting with methotrexate monotherapy is cost-effective - Commentary

AU - Huizinga, Tom

AU - Nigrovic, Peter

AU - Ruderman, Eric

AU - Schulze-Koops, Hendrik

PY - 2011

Y1 - 2011

UR - http://www.scopus.com/inward/record.url?scp=84863898637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863898637&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:84863898637

SN - 1478-856X

VL - 9

SP - 145

EP - 146

JO - International Journal of Advances in Rheumatology

JF - International Journal of Advances in Rheumatology

IS - 4

ER -

Treatment strategies aiming at remission in early rheumatoid arthritis patients: Starting with methotrexate monotherapy is cost-effective - Commentary

ASJC Scopus subject areas

Other files and links

Cite this